Rab5UAS.GFP/Scer\GAL4Toll-6-D42 is an enhancer of abnormal neurophysiology | third instar larval stage | dominant phenotype of Vps35MH20
Rab5UAS.GFP/Scer\GAL4da.G32 is a suppressor of abnormal size | third instar larval stage phenotype of Vps35MH20/Vps351
Rab5UAS.GFP/Scer\GAL4ple.PF is a suppressor of abnormal circadian behavior | dominant | adult stage phenotype of Vps351
Rab5UAS.GFP/Scer\GAL4da.G32 is a suppressor of abnormal locomotor behavior | dominant | third instar larval stage phenotype of Vps35MH20
Rab5UAS.GFP/Scer\GAL4da.G32 is a suppressor of type I terminal bouton | third instar larval stage phenotype of Vps35MH20/Vps351
Rab5UAS.GFP/Scer\GAL4da.G32 is a suppressor of synaptic vesicle | third instar larval stage phenotype of Vps35MH20/Vps351
The expression of Rab5Scer\UAS.T:Avic\GFP under the control of Scer\GAL4da.G32 suppresses the reciprocal increased number of type Ib boutons and reciprocal decreased bouton size, and suppresses the reciprocal increased size and decreased number of synaptic vesicles and in the third instar larval neuromuscular junctions of Vps351/Vps35MH20 transheterozygotes.
The expression of Rab5Scer\UAS.T:Avic\GFP under the control of Scer\GAL4ple.PF also suppresses the decreased sleep bouts displayed by Vps351 heterozygous adults.
The expression of Rab5Scer\UAS.T:Avic\GFP suppresses the decreased locomotor activity (expression driven by Scer\GAL4da.G32), while enhancing the decreased excitatory junction potential amplitude under high stimulation conditions at the neuromuscular junctions (expression driven by Scer\GAL4Toll-6-D42), observed in Vps35MH20 heterozygous third instar larvae.